ストックスクリーナーアプリを入手
1.90
5.47%
-0.11
アフターアワーズ：
1.90
前日終値:
$2.01
開ける：
$2.01
24時間の取引高:
21,284
Relative Volume:
0.04
時価総額：
$4.26M
収益：
-
当期純損益:
$-15.42M
株価収益率:
-1.0326
EPS:
-1.84
ネットキャッシュフロー:
$-13.41M
1週間 パフォーマンス:
-7.90%
1か月 パフォーマンス:
+22.58%
6か月 パフォーマンス:
-42.48%
1年 パフォーマンス:
+133.99%
1日の値動き範囲:
$1.85
$2.01
1週間の範囲:
$1.85
$2.17
52週間の値動き範囲:
$0.2701
$13.40
Indaptus Therapeutics Inc Stock (INDP) Company Profile
名前
Indaptus Therapeutics Inc
セクター
電話
(646) 427-2727
住所
3 COLUMBUS CIRCLE, NEW YORK
Compare INDP vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
1.90 | 4.51M | 0 | -15.42M | -13.41M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Indaptus Therapeutics Inc (INDP) 最新ニュース
Does Indaptus Therapeutics Inc. have declining or rising EPSPortfolio Profit Report & Daily Stock Momentum Reports - mfd.ru
Indaptus Therapeutics (INDP) Expected to Announce Quarterly Earnings on Thursday - Defense World
CapEx per share of Indaptus Therapeutics, Inc. – NASDAQ:INDP - TradingView
Lazar takes 98% control stake in Indaptus Therapeutics (INDP) via $6M deal - Stock Titan
Indaptus Therapeutics, Inc. Announces $3.0 Million Registered Direct Offering and Concurrent Private Placement - marketscreener.com
Indaptus Therapeutics shareholders approve preferred stock conversion and company charter amendments - Investing.com
Indaptus (INDP) director Jerome Jabbour awarded options on 25,000 shares - Stock Titan
Indaptus Therapeutics (NASDAQ: INDP) investors back control shift, share boost - Stock Titan
Indaptus Therapeutics (INDP) director Jerome Jabbour files initial Form 3 - Stock Titan
Rate Hike: Why is Indaptus Therapeutics Inc stock going up2025 Trading Recap & Weekly Stock Performance Updates - baoquankhu1.vn
INDP Should I Buy - Intellectia AI
Indaptus Therapeutics (INDP) director discloses holding 25,000 common shares - Stock Titan
INDP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Volume Summary: Can Champion Homes Inc reach resistance levels soonGap Up & Verified Swing Trading Watchlist - baoquankhu1.vn
INDP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Does Indaptus Therapeutics Inc. have a sustainable dividend2025 Technical Overview & Free Weekly Chart Analysis and Trade Guides - mfd.ru
Can Indaptus Therapeutics Inc. stock reach $100 price target2025 Support & Resistance & Accurate Buy Signal Notifications - mfd.ru
Indaptus Therapeutics Reprices Warrants to Bolster Shareholder Support - TipRanks
Indaptus Therapeutics Signs Multiple Material Agreements - TradingView
What’s the analyst consensus on Indaptus Therapeutics Inc.Market Volume Summary & Risk Controlled Daily Trade Plans - mfd.ru
Is Indaptus Therapeutics Inc. stock undervalued right nowJuly 2025 Review & Risk Managed Trade Strategies - mfd.ru
How Indaptus Therapeutics Inc. stock benefits from strong dollarMarket Rally & Real-Time Volume Trigger Notifications - mfd.ru
Published on: 2026-02-04 21:21:37 - baoquankhu1.vn
Is Indaptus Therapeutics Inc.’s ROE strong enough2025 Top Decliners & Target Return Focused Picks - mfd.ru
Retail Trends: Why is Indaptus Therapeutics Inc stock going down2025 Earnings Impact & Free High Return Stock Watch Alerts - baoquankhu1.vn
Update Recap: Whats next for Indaptus Therapeutics Inc stock2025 EndofYear Setup & Expert Approved Trade Ideas - baoquankhu1.vn
Insider Trends: Why is Indaptus Therapeutics Inc stock going up2025 Support & Resistance & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Indaptus Therapeutics adjusts executive salaries and board member rescinds resignation - Investing.com India
Indaptus Therapeutics cuts executive pay, director stays on - TipRanks
Indaptus Therapeutics adjusts executive salaries and board member rescinds resignation By Investing.com - Investing.com South Africa
Indaptus Therapeutics Announces Board Member Decision - TradingView — Track All Markets
Aug Wrap: Is Indaptus Therapeutics Inc stock a buy or sellMarket Risk Summary & AI Driven Price Forecasts - baoquankhu1.vn
MACD Signal: Is Indaptus Therapeutics Inc stock a good pick for beginnersEarnings Trend Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Will Indaptus Therapeutics Inc. stock recover faster than marketFit and Size Notes & lightweight options for faster days - ulpravda.ru
Indaptus Therapeutics Appoints David Natan to Board - The Globe and Mail
Indaptus Therapeutics appoints David Natan to board and audit committee By Investing.com - Investing.com Australia
Indaptus Therapeutics appoints David Natan to board and audit committee - Investing.com
Will Indaptus Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Technicals & Entry Point Confirmation Alerts - Улправда
How analysts rate Indaptus Therapeutics Inc. stock todayEarnings Risk Report & Weekly Hot Stock Watchlists - Улправда
Why did INDP stock gain 12% today? - MSN
Indaptus Therapeutics announces upcoming board leadership transition - MSN
Three Indaptus Therapeutics board members signal planned resignations By Investing.com - Investing.com Nigeria
Three Indaptus Therapeutics board members signal planned resignations - Investing.com
Indaptus Therapeutics Announces Board Resignations - TradingView — Track All Markets
Indaptus Therapeutics, Inc. (NASDAQ:INDP) Short Interest Up 25.9% in December - Defense World
Indaptus Therapeutics looks to raise $2.25M in private placement - MSN
Biotech Stocks To Keep An Eye OnDecember 24th - MarketBeat
Indaptus Therapeutics Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - marketscreener.com
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - The Globe and Mail
Indaptus Therapeutics secures $6 million investment, names new chairman By Investing.com - Investing.com Nigeria
Why Did INDP Stock Gain 12% Today? - Stocktwits
Indaptus Therapeutics Inc (INDP) 財務データ
収益
当期純利益
現金流量
EPS
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):